-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Reports In-Line Q3 EPS
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Tops Q1 EPS by 1c
-
-
-
-
-
-
-
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
-
-
-
-
-
-
-
Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Misses Q4 EPS by 58c
-
-
-
-
-
-
-
Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
1,197,257 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

